Wherever you turn you see reference to the effects of chronic inflammation related to heart disease, stroke, diabetes, and chronic kidney disease. Here is a link to a March, 2018 CAP Today article by Anne Paxton about the relationship of inflammatory biomarkers to chronic kidney disease in diabetes. George is especially interested in the tie-in to the fibrinolysis markers fibrinogen and plasminogen activator inhibitor-1 (PAI-1), which illustrate the relationship between hemostasis and inflammation.
Mar 26 2018
Comments (0)
Fibrinolysis
No comments here.